China Resources Boya Bio pharmaceutical Group Co Ltd (300294) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥43.70 Million ≈ $6.39 Million USD) by net assets (CN¥7.67 Billion ≈ $1.12 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

China Resources Boya Bio pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how China Resources Boya Bio pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300294 liabilities breakdown for a breakdown of total debt and financial obligations.

China Resources Boya Bio pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China Resources Boya Bio pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Savers Value Village, Inc. NYSE:SVV	0.208x
Shaanxi Provincial Natural Gas Co Ltd SHE:002267	0.032x
Nolato AB (publ) ST:NOLA-B	-0.080x
Guilin Fuda Co Ltd SHG:603166	0.019x
Forestar Group Inc NYSE:FOR	-0.088x
Shenzhen Vital New Material Co. Ltd. SHE:301319	N/A
Jiangsu Zhenjiang New Energy Equipment Co Ltd Class A SHG:603507	-0.028x
Kernel Holding SA F:0KE	-0.080x

Annual Cash Flow Conversion Efficiency for China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of China Resources Boya Bio pharmaceutical Group Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see China Resources Boya Bio pharmaceutical market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥7.49 Billion ≈ $1.10 Billion	CN¥299.78 Million ≈ $43.87 Million	0.040x	-54.33%
2023-12-31	CN¥7.32 Billion ≈ $1.07 Billion	CN¥641.73 Million ≈ $93.90 Million	0.088x	+7.06%
2022-12-31	CN¥7.28 Billion ≈ $1.07 Billion	CN¥596.44 Million ≈ $87.28 Million	0.082x	-57.88%
2021-12-31	CN¥6.92 Billion ≈ $1.01 Billion	CN¥1.35 Billion ≈ $196.87 Million	0.194x	+13.42%
2020-12-31	CN¥4.19 Billion ≈ $613.49 Million	CN¥718.58 Million ≈ $105.15 Million	0.171x	+697.00%
2019-12-31	CN¥3.99 Billion ≈ $583.66 Million	CN¥-114.51 Million ≈ $-16.76 Million	-0.029x	-410.15%
2018-12-31	CN¥3.77 Billion ≈ $551.75 Million	CN¥34.90 Million ≈ $5.11 Million	0.009x	+196.56%
2017-12-31	CN¥2.48 Billion ≈ $363.53 Million	CN¥-23.82 Million ≈ $-3.49 Million	-0.010x	-110.28%
2016-12-31	CN¥2.13 Billion ≈ $312.01 Million	CN¥198.76 Million ≈ $29.08 Million	0.093x	+20.98%
2015-12-31	CN¥1.91 Billion ≈ $279.22 Million	CN¥147.02 Million ≈ $21.51 Million	0.077x	-41.59%
2014-12-31	CN¥923.93 Million ≈ $135.20 Million	CN¥121.88 Million ≈ $17.84 Million	0.132x	+25.34%
2013-12-31	CN¥846.62 Million ≈ $123.89 Million	CN¥89.11 Million ≈ $13.04 Million	0.105x	-14.35%
2012-12-31	CN¥751.60 Million ≈ $109.98 Million	CN¥92.36 Million ≈ $13.52 Million	0.123x	-60.41%
2011-12-31	CN¥262.67 Million ≈ $38.44 Million	CN¥81.53 Million ≈ $11.93 Million	0.310x	+147.44%
2010-12-31	CN¥197.44 Million ≈ $28.89 Million	CN¥24.77 Million ≈ $3.62 Million	0.125x	-60.23%
2009-12-31	CN¥164.49 Million ≈ $24.07 Million	CN¥51.88 Million ≈ $7.59 Million	0.315x	--

About China Resources Boya Bio pharmaceutical Group Co Ltd

SHE:300294 China Biotechnology

Market Cap

$1.29 Billion

CN¥8.81 Billion CNY

Market Cap Rank

#8016 Global

#2011 in China

Share Price

CN¥17.48

Change (1 day)

-1.35%

52-Week Range

CN¥17.48 - CN¥27.67

All Time High

CN¥55.20